Literature DB >> 18211618

Frequencies of CYP3A5 genotypes and haplotypes in a Korean population.

S Y Park1, Y S Kang, M S Jeong, H K Yoon, K O Han.   

Abstract

BACKGROUND AND
OBJECTIVE: CYP3A, the drug-metabolizing enzyme is an important factor in the pharmacokinetics of many drugs. Polymorphism of the CYP3A5 gene is known to influence the functionality of the CYP3A5 enzymes. The full extent of CYP3A5 genetic polymorphism was analysed in a Korean population.
METHODS: Specific polymerase chain reaction-restriction fragment length polymorphism tests for CYP 3AP1 through CYP3A5*7 or direct sequencing were used to identify reported CYP3A5 variant alleles, using 194 unrelated samples. RESULTS AND DISCUSSION: The most frequent single nucleotide polymorphism (SNP) was 6986A>G (CYP3A5*3). The next most frequent SNP was 31611C>T. Haplotype analysis using detected SNPs revealed that the most frequent haplotype was *3A (frequency: 0.724), followed by *1E (frequency: 0.211), *3C (frequency: 0.034) and *1A (frequency: 0.023). We did not find CYP3AP1*3, CYP3A5*6, or *7 in this Korean sample.
CONCLUSION: A large proportion of Koreans may have relatively low levels of metabolically active CYP3A5 protein and therefore may be at risk of high levels of drugs metabolized by this enzyme, after administration of conventional doses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18211618     DOI: 10.1111/j.1365-2710.2008.00879.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  13 in total

1.  Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients.

Authors:  Nayoung Han; Hwi-yeol Yun; Jin-yi Hong; In-Wha Kim; Eunhee Ji; Su Hyun Hong; Yon Su Kim; Jongwon Ha; Wan Gyoon Shin; Jung Mi Oh
Journal:  Eur J Clin Pharmacol       Date:  2012-06-02       Impact factor: 2.953

2.  PharmGKB summary: very important pharmacogene information for CYP3A5.

Authors:  Jatinder Lamba; Joan M Hebert; Erin G Schuetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2012-07       Impact factor: 2.089

3.  Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.

Authors:  Al-Motassem Yousef; Nailya R Bulatova; William Newman; Nancy Hakooz; Said Ismail; Hisham Qusa; Farah Zahran; Nidaa Anwar Ababneh; Farah Hasan; Imad Zaloom; Ghada Khayat; Rawan Al-Zmili; Randa Naffa; Ola Al-Diab
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

4.  Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation.

Authors:  Khemjira Yaowakulpatana; Somratai Vadcharavivad; Atiporn Ingsathit; Nutthada Areepium; Surasak Kantachuvesiri; Bunyong Phakdeekitcharoen; Chonlaphat Sukasem; Supasil Sra-Ium; Vasant Sumethkul; Chagriya Kitiyakara
Journal:  Eur J Clin Pharmacol       Date:  2015-12-04       Impact factor: 2.953

5.  Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population.

Authors:  Gilberto Vargas-Alarcón; Julián Ramírez-Bello; Aurora de la Peña; Beatriz Calderón-Cruz; Marco Antonio Peña-Duque; Marco Antonio Martínez-Ríos; Silvestre Ramírez-Fuentes; Oscar Pérez-Méndez; José Manuel Fragoso
Journal:  Mol Biol Rep       Date:  2014-08-09       Impact factor: 2.316

6.  Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation.

Authors:  Eunhee Ji; Leena Choi; Kyung-Suk Suh; Joo-Youn Cho; Nayoung Han; Jung Mi Oh
Journal:  Transplantation       Date:  2012-10-27       Impact factor: 4.939

7.  The investigation of allele and genotype frequencies of CYP3A5 (1/3) and P2Y12 (T744C) in Iran.

Authors:  N Azarpira; S Namazi; A Khalili; M Tabesh
Journal:  Mol Biol Rep       Date:  2010-12-14       Impact factor: 2.316

Review 8.  Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Chandrasekaran Adithan
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

9.  Metabolism of Long-Acting Rilpivirine After Intramuscular Injection: HIV Prevention Trials Network Study 076 (HPTN 076).

Authors:  Herana Kamal Seneviratne; Joseph Tillotson; Julie M Lade; Linda-Gail Bekker; Sue Li; Subash Pathak; Jessica Justman; Nyaradzo Mgodi; Shobha Swaminathan; Nirupama Sista; Jennifer Farrior; Paul Richardson; Craig W Hendrix; Namandje N Bumpus
Journal:  AIDS Res Hum Retroviruses       Date:  2021-01-13       Impact factor: 2.205

10.  Molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa.

Authors:  Ripudaman K Bains; Mirna Kovacevic; Christopher A Plaster; Ayele Tarekegn; Endashaw Bekele; Neil N Bradman; Mark G Thomas
Journal:  BMC Genet       Date:  2013-05-03       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.